# Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

> **NCT02618109** · PHASE4 · TERMINATED · sponsor: **University Hospital, Angers** · enrollment: 119 (actual)

## Conditions studied

- B Acute Lymphoblastic Leukemia
- Leukemia Relapse

## Interventions

- **BIOLOGICAL:** Collection of blood samples

## Key facts

- **NCT ID:** NCT02618109
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 119 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2022-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618109, "Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02618109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*